cobas SARS-CoV-2 Nucleic acid test for use on the cobas Liat System
K223783 is the FDA 510(k) clearance record for cobas SARS-CoV-2 Nucleic acid test for use on the cobas Liat System, a class II device, cleared for Roche Molecular Systems, Inc. on under FDA product code QWR (Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings). FDA's definition for product code QWR reads: "A simple point-of-care device to detect SARS-CoV-2 nucleic acid targets directly from clinical specimens in near-patient settings is an in vitro diagnostic device for the direct detection of SARS-CoV-2 in clinical specimens and is intended...". FDA records list 53 510(k) clearances for Roche Molecular Systems, Inc., from to . As of , FDA records show no recalls naming K223783.
Clearance record
- Decision date
- Received
- (353 days to decision)
- Product code
- QWR Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings
- Regulation
- 21 CFR 866.3982
- Device class
- Class II
- Review panel
- Microbiology
- Applicant
- Roche Molecular Systems, Inc. 4300 Hacienda Dr., Pleasanton CA
- 510(k) summary
- Summary PDF
- Third party review
- No
Clearances, product code QWR
Trailing 12 monthsFDA records hold no clearances under product code QWR in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
